Full-Time

Senior Director Drug Safety and Pharmacovigilance

Posted on 6/18/2024

Acadia Pharmaceuticals Inc.

Acadia Pharmaceuticals Inc.

501-1,000 employees

Develops therapies for neurological disorders

Biotechnology

Senior

Princeton, NJ, USA

Required Skills
Communications
Requirements
  • MD degree or equivalent
  • 12 years of relevant drug safety experience in the biotechnology/pharmaceutical industry
  • MPH or pharmacoepidemiology expertise desired
  • Neurology, psychiatry, or CNS-related disease experience preferred
Responsibilities
  • Develop strategies to achieve PV Medical Safety goals
  • Represent PV in communications with health authorities
  • Assess safety signals and trends
  • Formulate response strategies for health authority requests
  • Provide oversight for safety aspects of clinical studies
  • Lead development of Risk Management Plans
  • Communicate safety issues to stakeholders
  • Author analysis of similar events and individual case comments for ICSRs
Acadia Pharmaceuticals Inc.

Acadia Pharmaceuticals Inc.

View

Acadia Pharmaceuticals Inc. stands out as a leader in the niche field of neurological and mental health therapy development, particularly focusing on conditions like schizophrenia, Parkinson's disease psychosis, and Rett syndrome. This specialization not only brings significant advancement in targeted therapies but also enhances the quality of life for individuals enduring these challenging conditions. Working at this company offers the chance to be part of a dedicated team that positively impacts patient lives through groundbreaking work in a highly specialized area of medicine.

Company Stage

IPO

Total Funding

$813.4M

Headquarters

San Diego, California

Founded

1993

Growth & Insights
Headcount

6 month growth

7%

1 year growth

14%

2 year growth

20%